BioDTech Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
BioDTech General Information
Description
Developer of specialty chemicals intended to accelerate the development of technologically advanced products geared towards the endotoxin market. The company's chemicals detect, neutralize and remove endotoxin associated with gram-negative bacteria and provide both quantitative and qualitative results to the end-users, thereby enabling scientists to design assays that are user-friendly and yield rapid, quantitative and specific results without expensive training or equipment.
Contact Information
Website
www.biodtechinc.comCorporate Office
- 2100 SouthBridge Parkway
- Suite 650
- Birmingham, AL 35209
- United States
Corporate Office
- 2100 SouthBridge Parkway
- Suite 650
- Birmingham, AL 35209
- United States
BioDTech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 27-May-2020 | Completed | Generating Revenue | |||
| 5. Merger/Acquisition | 28-Nov-2018 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Nov-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 25-Aug-2010 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Jul-2007 | $1M | $1.11M | Completed | Startup | |
| 1. Seed Round | 13-Jan-2005 | $110K | $110K | Completed | Startup |
BioDTech Comparisons
Industry
Financing
Details
BioDTech Competitors (3)
One of BioDTech’s 3 competitors is Eurofins Genomics Europe Shared Services, a Corporation company based in Ebersberg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Eurofins Genomics Europe Shared Services | Corporation | Ebersberg, Germany | ||||
| Numaferm | Venture Capital-Backed | Dusseldorf, Germany | ||||
| Integrated DNA Technologies | Formerly PE-Backed | Coralville, IA |
BioDTech Patents
BioDTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014022530-A1 | The use of endotoxin neutralization as a biomarker for sepsis | Inactive | 31-Jul-2012 | ||
| EP-2859355-A2 | The use of endotoxin neutralization as a biomarker for intestinal wall damage | Inactive | 08-Jun-2012 | ||
| EP-2859355-A4 | The use of endotoxin neutralization as a biomarker for intestinal wall damage | Inactive | 08-Jun-2012 | ||
| US-20150152470-A1 | The use of endotoxin neutralization as a biomarker for intestinal wall damage | Inactive | 08-Jun-2012 | ||
| WO-2013185029-A2 | The use of endotoxin neutralization as a biomarker for intestinal wall damage | Inactive | 08-Jun-2012 | C12Q1/37 |
BioDTech Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Greer Capital Advisors | Venture Capital | Minority | ||
| Innovation Depot | Accelerator/Incubator | Minority | ||
| Inventa Biotech | Corporation | Majority | ||
| Targeted Technology | Venture Capital | Minority |
BioDTech FAQs
-
When was BioDTech founded?
BioDTech was founded in 2003.
-
Where is BioDTech headquartered?
BioDTech is headquartered in Birmingham, AL.
-
What industry is BioDTech in?
BioDTech’s primary industry is Specialty Chemicals.
-
Is BioDTech a private or public company?
BioDTech is a Private company.
-
What is BioDTech’s current revenue?
The current revenue for BioDTech is .
-
How much funding has BioDTech raised over time?
BioDTech has raised $1.71M.
-
Who are BioDTech’s investors?
Greer Capital Advisors, Innovation Depot, Inventa Biotech, and Targeted Technology have invested in BioDTech.
-
Who are BioDTech’s competitors?
Eurofins Genomics Europe Shared Services, Numaferm, and Integrated DNA Technologies are competitors of BioDTech.
-
When was BioDTech acquired?
BioDTech was acquired on 27-May-2020.
-
Who acquired BioDTech?
BioDTech was acquired by Axe Compute.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process